dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Bokemeyer, Carsten |
dc.contributor.author | Dubreuil , Olivier |
dc.contributor.author | GUIGAY, Joel |
dc.contributor.author | Kasper, Stefan |
dc.contributor.author | Pfeiffer, Per |
dc.contributor.author | Ciardiello, Fortunato |
dc.contributor.author | Tabernero, Josep |
dc.date.accessioned | 2024-03-20T07:00:45Z |
dc.date.available | 2024-03-20T07:00:45Z |
dc.date.issued | 2024-03 |
dc.identifier.citation | Bokemeyer C, Ciardiello F, Dubreuil O, Guigay J, Kasper S, Pfeiffer P, et al. Cetuximab every 2 weeks versus standard weekly dosing administration schedule. Futur Oncol. 2024 Mar;20(7):393–407. |
dc.identifier.issn | 1744-8301 |
dc.identifier.uri | https://hdl.handle.net/11351/11209 |
dc.description | Programa de dosificació; Eficàcia; Farmacocinètica |
dc.language.iso | eng |
dc.publisher | Future Medicine |
dc.relation.ispartofseries | Future Oncology;20(7) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Càncer - Tractament |
dc.subject | Anticossos monoclonals - Ús terapèutic |
dc.subject.mesh | Antibodies, Monoclonal |
dc.subject.mesh | /therapeutic use |
dc.subject.mesh | Neoplasms |
dc.subject.mesh | /drug therapy |
dc.title | Cetuximab every 2 weeks versus standard weekly dosing administration schedule |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.2217/fon-2023-0282 |
dc.subject.decs | anticuerpos monoclonales |
dc.subject.decs | /uso terapéutico |
dc.subject.decs | neoplasias |
dc.subject.decs | /farmacoterapia |
dc.relation.publishversion | https://doi.org/10.2217/fon-2023-0282 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Bokemeyer C] The II Medical Clinic, Department of Oncology, Hematology & BMT with section of Pneumology, University Medical Center of Hamburg-Eppendorf, Hamburg, Germany. [Ciardiello F] Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy. [Dubreuil O] Medical Oncology Unit, Diaconesses-Croix St Simon Hospital, Paris, France. [Guigay J] Groupe d’Oncologie Radiothérapie Tête Et Cou (GORTEC), Tours, France. [Kasper S] Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany. [Pfeiffer P] Department of Oncology, Odense University Hospital, Odense, Denmark. [Tabernero J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron, UVic-UCC, Barcelona, Spain |
dc.identifier.pmid | 37850363 |
dc.identifier.wos | 001087969000001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |